Mr Rosenston comes to Halo from a long and distinguished career at Abbott Laboratories where he held diverse roles in operations, business development, and related business functions.
Mohd Asif, CFO of Halo, said: “The addition of Al to the Halo business development team is a significant achievement. Al has deep experience within the pharmaceutical industry. He developed Abbott’s domestic contract pharmaceutical manufacturing business unit and, at the time of his retirement, he was responsible for the global finished goods contract manufacturing business.”